Weigao Group (1066.HK) executes share buyback on HKEX

Shandong Weigao Group Medical Polymer Company Limited, listed on the HKEX under stock code 1066, has announced that it repurchased 60,000 ordinary shares on May 21, 2025. The shares were repurchased on the Exchange at prices ranging from HKD 5.96 to HKD 5.99 per share, with the total aggregate price paid amounting to HKD 358,600. This buyback represents approximately 0.0013% of the existing issued shares (excluding treasury shares). The company also noted that since May 28, 2024, the date of the resolution granting the repurchase mandate, it has repurchased a total of 6,157,200 shares. These buybacks align with the Main Board Rules and GEM Rules, with no material changes from the explanatory statement filed on April 30, 2024. As a result of the repurchase, the company's treasury shares increased to 6,157,200, leaving the total number of issued shares (excluding treasury shares) at 4,516,175,124. The company can not issue any new shares, or sell or transfer any treasury shares after the share repurchases set out until June 21, 2025.